The role of concentrated growth factor (CGF) in type 1 tympanoplasty
Open Access
- 23 April 2026
- journal article
- research article
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (8) , 1-8
Abstract
Background: The aim of this study was to investigate the efficacy of concentrated growth factor (CGF) in type 1 tympanoplasty. Methods: This study represents a retrospective analysis of a non-randomized interventional cohort study, included 60 patients who underwent primary type 1 tympanoplasty between November 2024 and July 2025. The patients were divided into those who received only a cartilage graft ( n = 30) and those who received a cartilage graft and CGF ( n = 30). The incidence rates of residual tympanic membrane perforation, audiological outcomes, and postoperative infection rates were compared. Results: The incidence rate of residual perforation was significantly lower in the CGF group than in the cartilage-only group. The audiological outcomes showed no significant differences between the groups. Postoperative infection was observed less frequently in the CGF group. Conclusion: CGF may represent a promising adjunct in type 1 tympanoplasty by potentially supporting graft integration and reducing residual perforation rates.Keywords
Funding Information
- University of Health Sciences
This publication has 15 references indexed in Scilit:
- Mastoid obliteration with bone dust mixed with concentrated growth factorAmerican Journal of Otolaryngology, 2025
- Concentrated growth factors as a graft material for endoscopic revision tympanoplastyScientific Reports, 2025
- Concentrated growth factors promote epithelization in the mastoid obliteration after canal wall down mastoidectomyBrazilian Journal of Otorhinolaryngology, 2025
- Platelet rich fibrin augmented tympanoplasty versus cartilage tympanoplasty: a randomized clinical trialEuropean Archives of Oto-Rhino-Laryngology, 2024
- Tensile strength, growth factor content and proliferation activities for two platelet concentrates of platelet-rich fibrin and concentrated growth factorJournal of Dental Sciences, 2020
- Impact of platelet-rich fibrin therapy in tympanoplasty type 1 surgery on graft survival and frequency-specific hearing outcomes: a retrospective analysis in patients with tympanic membrane perforation due to chronic otitis mediaThe Journal of Laryngology & Otology, 2019
- Quantification of growth factors in advanced platelet‐rich fibrin and concentrated growth factors and their clinical efficacy as adjunctive to the GTR procedure in periodontal intrabony defectsJournal of Periodontology, 2019
- Impact of the Degree of the Mastoid Pneumatization on Cartilage Type 1 Tympanoplasty SuccessJournal of Craniofacial Surgery, 2016
- Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)Trends in Biotechnology, 2009
- Hyaluronic acid fat graft myringoplasty: how we do itClinical Otolaryngology, 2008